abstract |
FIELD: medicine. n SUBSTANCE: antibody to the repelling signal molecule a (RGMa) is proposed. Also a pharmaceutical composition comprising the said antibody and a method for treatment, prevention, modulation or decrease of the severity of a disease or disorder associated with neurites degeneration is proposed. n EFFECT: invention can find further application in the therapy of neurodegenerative diseases such as multiple sclerosis. n 31 cl, 20 dwg, 4 tbl, 11 ex |